Friday, 27 September 2013

Venezuela Pharmaceuticals and Healthcare Report Q4 2013

Business Monitor International Market Research Reports
Market Reports Online XML Feed 
Complimentary Downloads

7 Days of Complimentary Downloads: 100,000+ Motion Backgrounds, Video Clips, Production Music Tracks, Sound Effects, Special Effects and More.
From our sponsors
Venezuela Pharmaceuticals and Healthcare Report Q4 2013
Sep 25th 2013, 00:00

Price: $ 1295  

BMI View: High inflation, currency devaluation, import and foreign currency controls, as well as other structurally distorting policies in Venezuela will continue to trouble the country's pharmaceutical market in Q413. We expect the market to grow below nominal GDP levels between 2012 and 2017, and experience a contraction in real growth terms. Low-cost generic drugs made in Cuba will continue to be an important resource for Venezuela to meet its local medicine demand. Headline Expenditure Projections ? Pharmaceuticals: VEB43.5bn (US$10.1bn) in 2012 to VEB53.3bn (US$8.8bn) in 2013; +22.6% in local currency terms and -13.3% in US dollar terms. Forecast downwards from Q313. ? Healthcare: VEB86.7bn (US$20.2bn) in 2012 to VEB107.1bn (US$17.6bn) in 2013; +23.5% in local currency terms and - ...

Complete report details with Table of Contents and more @

Delicious Digg Evernote Facebook Google Bookmarks Google Plus LinkedIn StumbleUpon Tumblr Twitter
You are receiving this email because you subscribed to this feed at

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment